
In the battle against Alzheimer’s disease and dementia, hope is on the horizon. With groundbreaking treatments like Leqembi (lecanemab) hitting the market and a robust pipeline of over 140 agents in development, health care providers are armed with potent tools. Alvaro Pascual-Leone, M.D., Ph.D., and Dr. John Showalter, M.D., experts in cognitive care, will guide you through this changing landscape. Learn about the power of early detection, the synergy of drug and lifestyle interventions, and the role of modern cognitive assessment tools in streamlining care.










